Veeda Clinical Research is a leading research organisation who provides services of Phase I/II Clinical Trials at Uk,invent new drugs in order to preserve human lives
March 11, 2006 (Press Release) --
The 15 billion dollar world of Clinical Research has a major new player in its
fastest growing sector, that of phase I clinical trials. Veeda Clinical Research(www.veedacr.com),
known as Veeda CR, brings together the highly respected UK CRO Phase 1 CTU
Ltd, ClinSearch Labs Pvt. Ltd. of Ahmedabad and Triphasic Clinical Trials
Laboratories a Plymouth, UK based, GLP accredited laboratory.
Veeda CR can count many of the world’s top ten Pharmaceutical Companies as
clients and sees huge potential in unleashing the synergies of its Indian -
European collaboration onto a global market place. Veeda CR’s revenue in India
currently stands at 32 crores and is expected to double over the next 12 months.
“Veeda CR represents the ideal bridge between cultures – combining vast
experience and expertise in handling the most technically complex trials to the
most stringent regulatory standards with the massive technical, data
management and volunteer capability of the Indian subcontinent” said Director
Mr. Apurva Shah.
Veeda CR sees its key attribute as its uncompromising commitment to quality
and it will use the recognised expertise of its European personnel to help train its
research professionals in India. This will be achieved by a two way traffic
between continents with research professionals from India undergoing intensive
training in the UK and Western project management skills following European
research projects into India.
Dr Kiran Marthak, a Director of Veeda CR, is delighted to have joined the Veeda
CR at this exciting juncture. Dr Marthak is a pioneer of clinical research activities
in India and brings to Veeda CR experience of working with pharmaceutical
majors such as Novartis, German Remedies, Pfizer, and Ranbaxy.
Dr Marthak said “We have managed to combine the best of a top 5 Early Clinical
Development Unit in the UK, with all the advantages of a vibrant new unit on the
Indian subcontinent, with both Units operating to exactly the same stringent
standards set by international regulatory authorities”
Veeda CR has adopted the image of the Bengal Tiger to exemplify its promise to
“Unleash the power of India”. Maurice Cross, a Director of Veeda CR’s said “our
marketing team was searching for an icon that represented the power, strength
and integrity of Veeda and was also indigenous to the Indian sub continent. Our
research gave us a number of interesting alternatives but the dignity and
overwhelming presence of the Bengal Tiger fit the bill perfectly. When we saw the
photograph it simply swept us away, both our UK and Indian colleagues were
unanimous in their enthusiasm for it. We understand Veeda means “knowledge”
and our tiger exudes knowledge and wisdom from every pore. It is a wonderful
symbol of both India and Veeda CR.”
© 2006 Veeda Clinical Research(www.veedacr.com)
The 15 billion dollar world of Clinical Research has a major new player in its
fastest growing sector, that of phase I clinical trials. Veeda Clinical Research(www.veedacr.com),
known as Veeda CR, brings together the highly respected UK CRO Phase 1 CTU
Ltd, ClinSearch Labs Pvt. Ltd. of Ahmedabad and Triphasic Clinical Trials
Laboratories a Plymouth, UK based, GLP accredited laboratory.
Veeda CR can count many of the world’s top ten Pharmaceutical Companies as
clients and sees huge potential in unleashing the synergies of its Indian -
European collaboration onto a global market place. Veeda CR’s revenue in India
currently stands at 32 crores and is expected to double over the next 12 months.
“Veeda CR represents the ideal bridge between cultures – combining vast
experience and expertise in handling the most technically complex trials to the
most stringent regulatory standards with the massive technical, data
management and volunteer capability of the Indian subcontinent” said Director
Mr. Apurva Shah.
Veeda CR sees its key attribute as its uncompromising commitment to quality
and it will use the recognised expertise of its European personnel to help train its
research professionals in India. This will be achieved by a two way traffic
between continents with research professionals from India undergoing intensive
training in the UK and Western project management skills following European
research projects into India.
Dr Kiran Marthak, a Director of Veeda CR, is delighted to have joined the Veeda
CR at this exciting juncture. Dr Marthak is a pioneer of clinical research activities
in India and brings to Veeda CR experience of working with pharmaceutical
majors such as Novartis, German Remedies, Pfizer, and Ranbaxy.
Dr Marthak said “We have managed to combine the best of a top 5 Early Clinical
Development Unit in the UK, with all the advantages of a vibrant new unit on the
Indian subcontinent, with both Units operating to exactly the same stringent
standards set by international regulatory authorities”
Veeda CR has adopted the image of the Bengal Tiger to exemplify its promise to
“Unleash the power of India”. Maurice Cross, a Director of Veeda CR’s said “our
marketing team was searching for an icon that represented the power, strength
and integrity of Veeda and was also indigenous to the Indian sub continent. Our
research gave us a number of interesting alternatives but the dignity and
overwhelming presence of the Bengal Tiger fit the bill perfectly. When we saw the
photograph it simply swept us away, both our UK and Indian colleagues were
unanimous in their enthusiasm for it. We understand Veeda means “knowledge”
and our tiger exudes knowledge and wisdom from every pore. It is a wonderful
symbol of both India and Veeda CR.”
© 2006 Veeda Clinical Research(www.veedacr.com)
Email
Print
SPAM
